Canada Drug Discovery Outsourcing Market, by Workflow (Target Identification and Screening, Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Others), by Therapeutic area (Respiratory system, Infectious disease, Oncology, Immunology, Hematology, Cardiovascular, Central Nervous System (CNS), Gastrointestinal, Others), by Drug Type (Small Molecules, Large Molecules), by End User (Pharmaceutical and Biotechnology companies, Academic Institutes, Others): Opportunity Analysis and Industry Forecast, 2021-2031

The report on the Canada drug discovery outsourcing market provides related insights, information, and recommendation to market stakeholder to achieve their priorities and enable the growth by taking the right decisions. The report is based on rigorous research methodology, which includes extensive desk research using quantitative/statistical methods, qualitative analysis, and primary interviews. This report examines the market scope, revenue size, and growth of the Canada drug discovery outsourcing market in value terms, and also tracks the key trends. Moreover, it includes qualitative analysis on different parameters such as impact on market size, regulatory framework, economic impact, key player strategies, and opportunity window. The company profile section of the report covers company overview, key executives, company snapshot, operating business segments, product/service portfolio, R&D expenditure, business performance, and key strategic moves & developments. The Canada drug discovery outsourcing market is segmented depending on workflow, therapeutic area, drug type, end user.

COVID-19 Impact Analysis

The eruption of the COVID-19 pandemic is projected to have a huge impact on the economic and social development. Therefore, the report portrays micro and macro economic analyses. The report further provides a qualitative analysis of impact of COVID-19 on the Canada drug discovery outsourcing market. Moreover, the study emphasizes on the market size and share, which will reflect the impact that COVID-19 has had on the Canada drug discovery outsourcing market initially and is likely to have in the subsequent years. In addition, the report outlines the key strategies adopted by key players during the global health crisis. Moreover, the roll-out of vaccines and decline in chance of infection are expected to influence the Canada drug discovery outsourcing market growth. Therefore, the report provides post COVID-19 impact analysis.

Deliverables:

• Market size value forecast

• Market trends and dynamics

• Porter’s Five Forces Model, PESTLE Analysis

• Company profile, competition landscape inclusive of competition dashboard, heatmap analysis, product/service offerings

• Key developmental strategies, M&A activities

• Market size and forecast for each segment

• Market Share of Leading Players worldwide

  Canada Drug Discovery Outsourcing Market Report Highlights

Aspects	Details
By Workflow	Target Identification and Screening Target Validation and Functional Informatics Lead Identification and Candidate Optimization Preclinical Development Others
By Therapeutic area	Hematology Cardiovascular Central Nervous System (CNS) Gastrointestinal Others Respiratory system Infectious disease Oncology Immunology
By Drug Type	Small Molecules Large Molecules
By End User	Pharmaceutical and Biotechnology companies Academic Institutes Others

Author Name(s) : Vikita Thakur| Shubham Sharma | Roshan Deshmukh

^*Terms and Conditions Apply